Error: Could not add to watchlist. X
+ Watchlist

Tekla Life Sciences Investors

XHQLX:US
NASDAQ GM
20.53
USD
0.21
1.03%
As of 9:29 AM EDT 3/29/2017
Fund Type
Closed-End Fund
52Wk Range
16.65 - 21.06
1 Yr Return
26.27%
YTD Return
15.44%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
20.32
52Wk Range
16.65 - 21.06
1 Yr Return
25.92%
YTD Return
15.44%
Fund Type
Closed-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
U.S.
NAV (on 03/29/2017)
20.53
Total Assets (m USD) (on 03/29/2017)
430.524
Inception Date
05/08/1992
Last Dividend (on 02/24/2017)
0.36
Dividend Indicated Gross Yield
7.01%
Fund Managers
DANIEL R OMSTEAD "DAN"
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
0.00%
Current Mgmt Fee
1.05%
Expense Ratio
1.32%

Top Fund Holdings

Name Position Value % of Fund
120.64 k 34.21 m 9.01
275.87 k 31.93 m 8.41
443.12 k 31.73 m 8.36
259.92 k 26.06 m 6.86
54.63 k 20.05 m 5.28
159.70 k 19.54 m 5.15
191.38 k 14.10 m 3.71
154.10 k 12.77 m 3.36
73.26 k 9.38 m 2.47
53.56 k 7.83 m 2.06
Profile
Tekla Life Sciences Investors is a diversified, closed-end management investment company incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests mainly in securities of life sciences companies and primarily in securities of public and private companies that are believed to have significant potential for above-average growth.
Address
H & Q Investors
2 Liberty Square, 9th Floor
Boston, MA 02109
USA
Phone
1-617-772-8500